 | Up a level |
Yousefzadeh, F. and Sahebolzamani, E. and Sadri, A. and Mortezaei, A. and Aqamolaei, A. and Mortazavi, S.H. and Shalbafan, M.R. and Ghaffari, S. and Alikhani, R. and Mousavi, S.B. and Naderi, S. and Shamabadi, A. and Jalilevand, S. and Akhondzadeh, S. (2020) 5-Hydroxytryptophan as adjuvant therapy in treatment of moderate to severe obsessive-compulsive disorder: A double-blind randomized trial with placebo control. International Clinical Psychopharmacology, 35 (5). pp. 254-262.
Ghaffari, S. and Ghobadi, A. and Jamshidi, A.H. and Mortazavi, S.H. and Naderi, S. and Aqamolaei, A. and Mortezaei, A. and Sahebolzamani, E. and Shamabadi, A. and Jalilvand, S. and Daraei, B. and Shalbafan, M.R. and Akhondzadeh, S. (2020) Cinnamomum tamala as an adjuvant therapy in the treatment of major depressive disorder: A double-blind, randomized, placebo-controlled clinical trial with placebo control. Advances in Integrative Medicine, 7 (3). pp. 141-147.
Borhannejad, F. and Shariati, B. and Naderi, S. and Shalbafan, M. and Mortezaei, A. and Sahebolzamani, E. and Saeb, A. and Hosein Mortazavi, S. and Kamalzadeh, L. and Aqamolaei, A. and Ali Noorbala, A. and Namazi-Shabestari, A. and Akhondzadeh, S. (2020) Comparison of vortioxetine and sertraline for treatment of major depressive disorder in elderly patients: A double-blind randomized trial. Journal of Clinical Pharmacy and Therapeutics, 45 (4). pp. 804-811.
Araminia, B. and Shalbafan, M. and Mortezaei, A. and Shirazi, E. and Ghaffari, S. and Sahebolzamani, E. and Mortazavi, S.H. and Shariati, B. and Ardebili, M.E. and Aqamolaei, A. and Naderi, S. and Akhondzadeh, S. (2020) L-Carnosine combination therapy for major depressive disorder: A randomized, double-blind, placebo-controlled trial. Journal of Affective Disorders, 267. pp. 131-136.
